Syphilis (Treponema pallidum)
Overview
Plain-Language Overview
Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. It primarily affects the skin, mucous membranes, and nervous system. The infection progresses through distinct stages, each with different symptoms, including painless sores, rashes, and potentially serious complications if untreated. It can spread through direct contact with infectious lesions during sexual activity. If left untreated, it can cause damage to the heart, brain, and other organs. Early detection and diagnosis are important to prevent long-term health problems.
Clinical Definition
Syphilis is a chronic systemic infection caused by the spirochete bacterium Treponema pallidum. It is transmitted primarily through sexual contact and progresses through primary, secondary, latent, and tertiary stages. The primary stage is characterized by a painless chancre at the site of inoculation. Secondary syphilis presents with a widespread maculopapular rash and mucocutaneous lesions. Latent syphilis is asymptomatic but serologically positive. Tertiary syphilis can cause gummatous lesions, cardiovascular syphilis, and neurosyphilis, which have significant morbidity. Diagnosis relies on serologic testing and clinical findings.
Inciting Event
Direct contact with infectious lesions during sexual activity initiates infection.
Exposure to infectious mucous membranes or abraded skin allows spirochete entry.
Vertical transmission from mother to fetus during pregnancy or delivery.
Latency Period
Primary syphilis develops within 10-90 days after exposure, typically around 3 weeks.
Secondary syphilis symptoms appear 4-10 weeks after the primary chancre.
Latent syphilis can last months to years without symptoms before tertiary manifestations.
Congenital syphilis symptoms may present at birth or within the first few months of life.
Diagnostic Delay
Painless chancre often goes unnoticed leading to missed primary diagnosis.
Non-specific secondary symptoms such as rash and lymphadenopathy mimic other diseases.
Lack of routine screening in asymptomatic individuals delays detection during latency.
False-negative serologic tests in early primary syphilis can complicate diagnosis.
Misattribution of neurological or cardiovascular symptoms to other causes delays recognition of tertiary syphilis.
Clinical Presentation
Signs & Symptoms
Painless genital ulcer (chancre) is the hallmark of primary syphilis.
Diffuse rash involving palms and soles occurs in secondary syphilis along with systemic symptoms like fever.
Mucous patches and condyloma lata are common mucocutaneous manifestations in secondary syphilis.
Patchy hair loss (moth-eaten alopecia) can be seen in secondary syphilis.
Neurosyphilis symptoms include headache, cranial nerve palsies, and cognitive changes.
Cardiovascular syphilis may present with chest pain or heart failure symptoms in tertiary disease.
History of Present Illness
Painless ulcer (chancre) at the site of inoculation marks primary syphilis onset.
Generalized maculopapular rash including palms and soles develops in secondary syphilis.
Systemic symptoms such as fever, malaise, and lymphadenopathy accompany secondary stage.
Asymptomatic latent phase follows secondary syphilis with no clinical signs.
Late manifestations include gummatous lesions, aortitis, and neurosyphilis presenting months to years later.
Past Medical History
Previous sexually transmitted infections increase risk of syphilis acquisition.
HIV infection alters clinical course and increases risk of neurosyphilis.
History of untreated or inadequately treated syphilis predisposes to tertiary disease.
Prior antibiotic use may partially treat syphilis and mask symptoms.
Family History
Congenital syphilis occurs in infants born to untreated infected mothers.
No known heritable genetic predisposition to syphilis infection or progression.
Family history of sexually transmitted infections may indicate shared risk behaviors.
Physical Exam Findings
A painless chancre with a clean base and indurated border is typical in primary syphilis.
Generalized, non-tender lymphadenopathy often accompanies early infection.
Diffuse maculopapular rash involving the palms and soles is characteristic of secondary syphilis.
Condyloma lata, broad-based, moist, wart-like lesions in intertriginous areas, appear in secondary syphilis.
Gummas, granulomatous lesions, may be found in tertiary syphilis affecting skin, bone, or organs.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of syphilis is established by a combination of clinical findings and serologic tests. Initial screening is typically done with a nontreponemal test such as the Rapid Plasma Reagin (RPR) or Venereal Disease Research Laboratory (VDRL) test. Positive results are confirmed with a treponemal-specific test like the Fluorescent Treponemal Antibody Absorption (FTA-ABS) or Treponema pallidum particle agglutination assay (TP-PA). Direct visualization of Treponema pallidum by darkfield microscopy from lesion exudate can also confirm early infection. Diagnosis requires correlation of test results with clinical presentation.
Pathophysiology
Key Mechanisms
Spirochete invasion of mucous membranes or skin leading to local infection and systemic dissemination.
Immune-mediated inflammation causing characteristic lesions such as chancres and gummas.
Endarteritis obliterans resulting in ischemic tissue damage in tertiary syphilis.
Neurosyphilis due to direct invasion of the central nervous system by Treponema pallidum.
Placental transmission causing congenital syphilis with multisystem involvement.
| Involvement | Details |
|---|---|
| Organs | Heart can be affected in tertiary syphilis causing syphilitic aortitis and aneurysm formation. |
Central nervous system involvement in neurosyphilis leads to meningitis, stroke, and cognitive decline. | |
Liver may show periportal inflammation and granulomas in secondary syphilis. | |
| Tissues | Skin is the primary site of chancre formation in primary syphilis and rash in secondary syphilis. |
Mucous membranes of the genitalia and oral cavity are commonly involved in syphilitic lesions and transmission. | |
Blood vessels can develop endarteritis obliterans in tertiary syphilis, leading to ischemic tissue damage. | |
| Cells | Plasma cells produce antibodies against Treponema pallidum during the immune response in syphilis. |
Macrophages phagocytose spirochetes and present antigens to activate adaptive immunity in syphilitic lesions. | |
T helper cells coordinate the immune response by releasing cytokines that recruit other immune cells to infected tissues. | |
| Chemical Mediators | Tumor necrosis factor-alpha (TNF-α) is elevated in syphilitic inflammation and contributes to tissue damage and granuloma formation. |
Interferon-gamma (IFN-γ) activates macrophages to enhance killing of Treponema pallidum in infected tissues. | |
C-reactive protein (CRP) levels may be elevated as a nonspecific marker of systemic inflammation in secondary syphilis. |
Treatments
Pharmacological Treatments
Benzathine penicillin G
- Mechanism:
Inhibits bacterial cell wall synthesis by binding penicillin-binding proteins, leading to lysis of Treponema pallidum.
- Side effects:
Jarisch-Herxheimer reaction
Allergic reactions
Injection site pain
- Clinical role:
First-line
Doxycycline
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, effective against Treponema pallidum in penicillin-allergic patients.
- Side effects:
Photosensitivity
Gastrointestinal upset
Tooth discoloration in children
- Clinical role:
Second-line
Ceftriaxone
- Mechanism:
Third-generation cephalosporin that inhibits bacterial cell wall synthesis, used as an alternative in penicillin allergy.
- Side effects:
Allergic reactions
Biliary sludge
Injection site reactions
- Clinical role:
Second-line
Non-pharmacological Treatments
Counseling on safe sexual practices to prevent transmission of syphilis.
Regular follow-up with serologic testing to monitor treatment response and detect reinfection.
Screening and treatment of sexual partners to control spread of Treponema pallidum.
Prevention
Pharmacological Prevention
Benzathine penicillin G administered to exposed individuals prevents progression to active disease.
Post-exposure prophylaxis with penicillin is recommended for sexual contacts of infectious cases.
Routine screening and early treatment in high-risk populations reduce transmission rates.
HIV pre-exposure prophylaxis (PrEP) indirectly reduces syphilis risk by decreasing risky sexual behaviors.
Treatment of co-infections with appropriate antibiotics helps prevent syphilis complications.
Non-pharmacological Prevention
Consistent condom use significantly reduces transmission of Treponema pallidum during sexual activity.
Regular screening of high-risk populations enables early detection and treatment.
Partner notification and treatment prevent reinfection and further spread.
Abstinence or mutual monogamy with an uninfected partner effectively prevents syphilis.
Education on safe sexual practices is critical for reducing incidence in vulnerable groups.
Outcome & Complications
Complications
Neurosyphilis causing meningitis, tabes dorsalis, or general paresis is a serious complication.
Cardiovascular syphilis can lead to aortitis, aortic aneurysm, or aortic valve insufficiency.
Congenital syphilis results from vertical transmission causing severe fetal and neonatal morbidity.
Gummatous lesions cause tissue destruction in skin, bone, and other organs.
Jarisch-Herxheimer reaction is an acute febrile response to antibiotic treatment.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Syphilis (Treponema pallidum) versus Herpes Simplex Virus (HSV) Infection
Syphilis (Treponema pallidum) | Herpes Simplex Virus (HSV) Infection |
|---|---|
Painless, indurated chancre | Painful vesicular lesions that ulcerate |
Single primary lesion with progression through stages | Recurrent episodes of lesions |
Positive darkfield microscopy or treponemal antibody test | Positive PCR or viral culture for HSV |
Syphilis (Treponema pallidum) versus Chancroid (Haemophilus ducreyi Infection)
Syphilis (Treponema pallidum) | Chancroid (Haemophilus ducreyi Infection) |
|---|---|
Painless, hard chancre with clean base | Painful, soft ulcer with ragged edges |
Non-tender, rubbery lymphadenopathy | Tender, suppurative inguinal lymphadenopathy |
Spirochete visualized by darkfield microscopy | Gram-negative coccobacillus on culture |
Syphilis (Treponema pallidum) versus Lymphogranuloma Venereum (Chlamydia trachomatis L1-L3)
Syphilis (Treponema pallidum) | Lymphogranuloma Venereum (Chlamydia trachomatis L1-L3) |
|---|---|
Non-tender, rubbery lymphadenopathy | Painful, unilateral inguinal lymphadenopathy with suppuration |
Painless, persistent chancre | Small, transient genital ulcer often unnoticed |
Positive treponemal antibody test | Positive nucleic acid amplification test for Chlamydia trachomatis L1-L3 |
Syphilis (Treponema pallidum) versus Granuloma Inguinale (Klebsiella granulomatis Infection)
Syphilis (Treponema pallidum) | Granuloma Inguinale (Klebsiella granulomatis Infection) |
|---|---|
Painless, indurated chancre with clean base | Painless, beefy-red granulomatous ulcer that bleeds easily |
Presence of spirochetes on darkfield microscopy | Presence of Donovan bodies in macrophages |
Primary lesion followed by systemic dissemination if untreated | Chronic progressive ulcer without regional lymphadenopathy |
Syphilis (Treponema pallidum) versus Fixed Drug Eruption
Syphilis (Treponema pallidum) | Fixed Drug Eruption |
|---|---|
Single painless chancre progressing through syphilis stages | Recurrent, well-demarcated erythematous patches or plaques at same site |
History of sexual exposure to infected partner | Recent exposure to offending medication |
Progressive disease without treatment | Lesions resolve with drug withdrawal and recur on re-exposure |